‘COVID-19 Drug’ Favipiravir to be available at Rs 103 Per Tablet
TNI Bureau: Glenmark Pharmaceuticals received manufacturing and marketing approval to use Favipiravir (of FabiFlu series) as the first oral anti-viral medication in India for the treatment of COVID-19.
The Favipiravir will be used for…